BioCentury
ARTICLE | Politics & Policy

Uhl named acting director of FDA's Office of Generic Drugs

March 20, 2013 12:28 AM UTC

According to an internal memo from Janet Woodcock, director of FDA's Center for Drug Evaluation and Research (CDER), Kathleen Uhl will serve as acting director of the agency's Office of Generic Drugs ...